XML 82 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Significant Accounting Policies
12 Months Ended
Jun. 30, 2013
Summary Of Significant Accounting Policies [Abstract]  
Summary Of Significant Accounting Policies

(2)            Summary of Significant Accounting Policies

 

 

(a)            Basis of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries.  All significant inter-company transactions and balances have been eliminated in consolidation.

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management estimates and assumptions that affect amounts reported in the consolidated financial statements and accompanying notes.  Actual results could differ from management’s estimates.

 

(b)            Revenue Recognition

 

We generally record revenue on product sales at the time of shipment, which is when title transfers to the customer. We do not record revenue on product sales which require customer acceptance until we receive acceptance. We initially defer service revenue received in advance from service contracts and recognize that deferred revenue ratably over the life of the service contract. We initially defer revenue we receive in advance from rental unit contracts and recognize that deferred revenue ratably over the life of the rental contract. Otherwise, we recognize revenue from rental unit contracts ratably over the life of the rental contract. We include in revenue freight charges we bill to customers. We charge all freight-related expenses to cost of sales.  Taxes assessed by government authorities that are imposed on and concurrent with revenue-producing transactions, such as sales and value added taxes, are excluded from revenue.

 

We do not recognize revenues to the extent that we offer a right of return or other recourse with respect to the sale of our products, other than returns for product defects or other warranty claims, nor do we recognize revenues if we offer variable sale prices for subsequent events or activities. However, as part of our sales processes we may provide upfront discounts for large orders, one-time special pricing to support new product introductions, sales rebates for centralized purchasing entities or price-breaks for regular order volumes. We record the costs of all such programs as an adjustment to revenue. Our products are predominantly therapy-based equipment and require no installation. Therefore, we have no installation obligations.

 

(c)            Cash and Cash Equivalents

 

Cash equivalents include certificates of deposit and other highly liquid investments and we state them at cost, which approximates market.  We consider investments with original maturities of 90 days or less to be cash equivalents for purposes of the consolidated statements of cash flows.

 

Our cash and cash equivalents balance at June 30, 2013, include $90.5 million in cash which is subject to a notice period of 90 days.  These cash balances earn interest rates above normal term deposit rates otherwise available and are held at highly rated financial institutions.

 

(d)            Inventories

 

We state inventories at the lower of cost (determined principally by the first-in, first-out method) or net realizable value.  We include material, labor and manufacturing overhead costs in finished goods and work-in-process inventories.  We review and provide for any product obsolescence in our manufacturing and distribution operations by assessing throughout the year individual products and components (based on estimated future usage and sales).

 

 

(2)            Summary of Significant Accounting Policies, Continued

 

(e)            Property, Plant and Equipment

 

We record property, plant and equipment, including rental equipment at cost.  We compute depreciation expense using the straight-line method over the estimated useful lives of the assets.  Useful lives are generally two to ten years except for buildings which are depreciated over an estimated useful life of 40 years and leasehold improvements, which we amortize over the lease term.  We charge maintenance and repairs to expense as we incur them.

 

(f)            Intangible Assets

 

We capitalize the registration costs for new patents and amortize the costs over the estimated useful life of the patent, which is generally five years.  If a patent is superseded or a product is retired, any unamortized costs are written off immediately.

 

We amortize all of our other intangible assets on a straight-line basis over their estimated useful lives, which range from two to nine years. We evaluate the recoverability of intangible assets periodically and take into account events or circumstances that warrant revised estimates of useful lives or that indicate that impairment exists.  We have not identified any impairment of intangible assets during any of the periods presented.

 

(g)            Goodwill

 

We conducted our annual review for goodwill impairment during the final quarter of fiscal 2013 using a quantitative assessment.  In conducting our review of goodwill impairment, we identified 8  reporting units, being components of our operating segment. The fair value for each reporting unit was determined based on estimated discounted cash flows. Our goodwill impairment review involved a two-step process as follows:

 

 

 

Step 1-

Compare the fair value for each reporting unit to its carrying value, including goodwill. For each reporting unit where the carrying value, including goodwill, exceeds the reporting unit’s fair value, move on to step 2. If a reporting unit’s fair value exceeds the carrying value, no further work is performed and no impairment charge is necessary.

Step 2-

Allocate the fair value of the reporting unit to its identifiable tangible and non-goodwill intangible assets and liabilities. This will derive an implied fair value for the goodwill. Then, compare the implied fair value of the reporting unit’s goodwill with the carrying amount of the reporting unit’s goodwill. If the carrying amount of the reporting unit’s goodwill is greater than the implied fair value of its goodwill, an impairment loss must be recognized for the excess.

 

The results of Step 1 of our annual review indicated that no impaired goodwill exists as the fair value for each reporting unit significantly exceeded its carrying value.

 

(h)            Foreign Currency

 

The consolidated financial statements of our non-U.S. subsidiaries, whose functional currencies are other than the U.S. dollar, are translated into U.S. dollars for financial reporting purposes.  We translate assets and liabilities of non-U.S. subsidiaries whose functional currencies are other than the U.S. dollar at period end exchange rates, but translate revenue and expense transactions at average exchange rates for the period.  We recognize cumulative translation adjustments as part of comprehensive income, as detailed in the Consolidated Statements of Comprehensive Income, and include those adjustments in accumulated other comprehensive income in the consolidated balance sheets until such time the relevant subsidiary is sold or substantially or completely liquidated.  We reflect gains and losses on transactions denominated in other than the functional currency of an entity in our results of operations.

 

(2)            Summary of Significant Accounting Policies, Continued

 

(i)            Research and Development

 

            We record all research and development expenses in the period we incur them.

 

(j)            Financial Instruments

 

The carrying value of financial instruments, such as cash and cash equivalents, accounts receivable and accounts payable, approximate their fair value because of their short-term nature. The carrying value of long-term debt approximates its fair value as the principal amounts outstanding are subject to variable interest rates that are based on market rates which are regularly reset.  Foreign currency option contracts are marked to market and therefore reflect their fair value. We do not hold or issue financial instruments for trading purposes.

 

The fair value of financial instruments is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.   

 

 (k)            Foreign Exchange Risk Management

 

We enter into various types of foreign exchange contracts in managing our foreign exchange risk, including derivative financial instruments encompassing forward exchange contracts and foreign currency options.

 

The purpose of our foreign currency hedging activities is to protect us from adverse exchange rate fluctuations with respect to net cash movements resulting from the sales of products to foreign customers and Australian and Singapore manufacturing activities. We enter into foreign currency option contracts to hedge anticipated sales and manufacturing costs, principally denominated in Australian and Singapore dollars, and Euros. The terms of such foreign currency option contracts generally do not exceed three years.

 

We have determined our hedge program to be a non-effective hedge as defined.  We record the foreign currency derivatives portfolio at fair value and include it in other assets and accrued expenses in our consolidated balance sheets.  We do not offset the fair value amounts recognized for foreign currency derivatives.  We classify purchases of foreign currency derivatives and proceeds received from the exercise of foreign currency derivatives as an investing activity within our consolidated statements of cash flows.

 

We record all movements in the fair value of the foreign currency derivatives within other income, net in our consolidated statements of income.

 

(l)            Income Taxes

 

We account for income taxes under the asset and liability method. We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. We measure deferred tax assets and liabilities using the enacted tax rates we expect to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

(m)        Allowance for Doubtful Accounts

 

We maintain an allowance for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments, which results in bad debt expense. We determine the adequacy of this allowance by periodically evaluating individual customer receivables, considering a customer’s financial condition, credit history and current economic conditions.  We are also contingently liable, within certain limits, in the event of a customer default, to several independent leasing companies in connection with customer leasing programs.  We monitor the collection status of these installment receivables and provide for estimated losses separately under accrued expenses within our consolidated balance sheets based upon our historical collection experience with such receivables and a current assessment of our credit exposure.  

    

 

 

 (2)            Summary of Significant Accounting Policies, Continued

 

(n)       Impairment of Long-Lived Assets

 

We periodically evaluate the carrying value of long-lived assets to be held and used, including certain identifiable intangible assets, when events and circumstances indicate that the carrying amount of an asset may not be recovered. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If assets are considered to be impaired, we recognize as the impairment the amount by which the carrying amount of the assets exceeds the fair value of the assets. We report assets to be disposed of at the lower of the carrying amount or fair value less costs to sell.

 

During the year ended June 30, 2013, 2012 and 2011, we recognized an impairment charge of $Nil,  $Nil and $2.3 million, respectively, relating to impaired long-lived assets that were no longer in use.  The impairment charge related to the long-lived assets, in fiscal year 2011, was recorded in cost of sales in our consolidated statements of income.